Voquezna — Highmark
Helicobacter pylori (H. pylori) infection
Initial criteria
- age ≥ 18 years
- diagnosis of H. pylori infection (ICD-10: B96.81) confirmed by one of the following: invasive techniques (e.g., endoscopic) OR non-invasive techniques (e.g., urea breath test, stool antigen assay test)
- Voquezna is being used in combination with amoxicillin OR in combination with amoxicillin and clarithromycin
Approval duration
14 days